Nephros, Inc.
NEPH
$3.42
-$0.13-3.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 155.70% | 104.70% | 49.48% | 21.91% | 40.75% |
| Total Depreciation and Amortization | -26.29% | -35.98% | -29.82% | 8.64% | -8.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.02% | -49.94% | 18.23% | 47.70% | 38.62% |
| Change in Net Operating Assets | -384.59% | -418.44% | -269.71% | -208.35% | -220.36% |
| Cash from Operations | 514.88% | -159.49% | -333.95% | -376.22% | 87.79% |
| Capital Expenditure | 26.67% | 26.67% | -- | -- | 27.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 33.33% | 33.33% | -- | -- | 27.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 42.86% | 93.67% | 95.51% | 95.51% | 96.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.86% | 93.67% | 96.26% | 96.26% | 97.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 320.69% | -181.28% | -417.45% | -916.67% | 84.92% |